Cenci MA - Search Results

1

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.

Iderberg H, Rylander D, Bimpisidis Z, Cenci MA. Iderberg H, et al. Among authors: cenci ma. Exp Neurol. 2013 Dec;250:116-24. doi: 10.1016/j.expneurol.2013.09.003. Epub 2013 Sep 10. Exp Neurol. 2013. PMID: 24029003

2

Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Cenci MA. Cenci MA. Amino Acids. 2002;23(1-3):105-9. doi: 10.1007/s00726-001-0116-4. Amino Acids. 2002. PMID: 12373525

3

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

Lundblad M, Usiello A, Carta M, Håkansson K, Fisone G, Cenci MA. Lundblad M, et al. Among authors: cenci ma. Exp Neurol. 2005 Jul;194(1):66-75. doi: 10.1016/j.expneurol.2005.02.002. Exp Neurol. 2005. PMID: 15899244

4

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

Lane EL, Winkler C, Brundin P, Cenci MA. Lane EL, et al. Among authors: cenci ma. Neurobiol Dis. 2006 May;22(2):334-45. doi: 10.1016/j.nbd.2005.11.011. Epub 2006 Jan 10. Neurobiol Dis. 2006. PMID: 16406222

5

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.

Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA. Carta M, et al. Among authors: cenci ma. J Neurochem. 2006 Mar;96(6):1718-27. doi: 10.1111/j.1471-4159.2006.03696.x. J Neurochem. 2006. PMID: 16539687 Free article.

6

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.

Cenci MA, Lundblad M. Cenci MA, et al. J Neurochem. 2006 Oct;99(2):381-92. doi: 10.1111/j.1471-4159.2006.04124.x. Epub 2006 Aug 29. J Neurochem. 2006. PMID: 16942598 Free article. Review.

7

The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.

Lindgren HS, Rylander D, Ohlin KE, Lundblad M, Cenci MA. Lindgren HS, et al. Among authors: cenci ma. Behav Brain Res. 2007 Feb 12;177(1):150-9. doi: 10.1016/j.bbr.2006.09.019. Epub 2006 Dec 8. Behav Brain Res. 2007. PMID: 17157933

8

Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.

Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA. Mela F, et al. Among authors: cenci ma. J Neurochem. 2007 Apr;101(2):483-97. doi: 10.1111/j.1471-4159.2007.04456.x. Epub 2007 Jan 15. J Neurochem. 2007. PMID: 17359492 Free article.

9

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia.

Cenci MA. Cenci MA. Trends Neurosci. 2007 May;30(5):236-43. doi: 10.1016/j.tins.2007.03.005. Epub 2007 Apr 2. Trends Neurosci. 2007. PMID: 17400300 Review.

10

Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.

Valastro B, Dekundy A, Krogh M, Lundblad M, James P, Danysz W, Quack G, Cenci MA. Valastro B, et al. Among authors: cenci ma. J Neurochem. 2007 Aug;102(4):1395-409. doi: 10.1111/j.1471-4159.2007.04655.x. Epub 2007 May 26. J Neurochem. 2007. PMID: 17532790 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters